{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:36:34Z","timestamp":1790264194794,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Coalition against Typhoid"},{"DOI":"10.13039\/100004107","name":"Sabin Vaccine Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.1093\/cid\/ciy884","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T17:03:10Z","timestamp":1539190990000},"page":"S22-S26","source":"Crossref","is-referenced-by-count":66,"title":["Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans"],"prefix":"10.1093","volume":"68","author":[{"given":"Sushant","family":"Sahastrabuddhe","sequence":"first","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Saluja","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"key\n\t\t\t\t2019021500095836100_CIT0001","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0002","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(05)67181-4","article-title":"Typhoid and paratyphoid fever","volume":"366","author":"Bhan","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0003","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-micro-091313-103739","article-title":"Salmonella enterica serovar Typhi and the pathogenesis of typhoid fever","volume":"68","author":"Dougan","year":"2014","journal-title":"Annu Rev Microbiol"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0004","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.75.3.214","article-title":"Impact of age and drug resistance on mortality in typhoid fever","volume":"75","author":"Bhutta","year":"1996","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00001432-199810000-00010","article-title":"Epidemiology, diagnosis and treatment of enteric fever","volume":"11","author":"Parry","year":"1998","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0006","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3855\/jidc.1967","article-title":"Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan","volume":"6","author":"Khan","year":"2012","journal-title":"J Infect Dev Ctries"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0007","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0008","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0009","volume-title":"Guidelines on the quality, safety and efficacy of typhoid conjugate vaccines","author":"World Health Organization","year":"2013"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0010","first-page":"49","article-title":"Typhoid vaccines: WHO position paper","volume":"83","author":"World Health Organization","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0011","unstructured":"WHO Strategic Advisory Group of Experts (SAGE) on Immunization. 2017. Available at: http:\/\/www.who.int\/imunization\/sage\/en\/index.html. Accessed October 2017."},{"key":"key\n\t\t\t\t2019021500095836100_CIT0012","unstructured":"World Health Organization. WHO Model List of Essential Medicines (19th List), April 2015. Available at: http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/EML2015_8-May-15.pdf."},{"key":"key\n\t\t\t\t2019021500095836100_CIT0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/9780470699836","volume-title":"Bioinformatics for vaccinology","author":"Flower","year":"2008"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0014","doi-asserted-by":"crossref","first-page":"S552","DOI":"10.1093\/clinids\/11.Supplement_3.S552","article-title":"Progress in vaccines against typhoid fever","volume":"11","author":"Levine","year":"1989","journal-title":"Rev Infect Dis"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0015","first-page":"957","article-title":"Vaccination against typhoid fever: present status","volume":"72","author":"Ivanoff","year":"1994","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0016","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0017","volume-title":"10th International Conference on Typhoid and Other Invasive Salmonelloses. April 4\u20136, 2017"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0018","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0019","first-page":"CD001261","article-title":"Vaccines for preventing typhoid fever","author":"Fraser","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-3083.2003.01292.x","article-title":"Mucosal vaccination against encapsulated respiratory bacteria\u2013new potentials for conjugate vaccines","volume":"58","author":"Jakobsen","year":"2003","journal-title":"Scand J Immunol"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0021","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1084\/jem.166.5.1510","article-title":"Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever","volume":"166","author":"Szu","year":"1987","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0022","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/IAI.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0023","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0024","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Lanh","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0025","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0026","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0027","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/S0140-6736(17)32407-8","article-title":"Typhoid vaccine development with a human challenge model","volume":"390","author":"Feasey","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0028","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/cix1145","article-title":"Seroefficacy of Vi polysaccharide-tetanus toxoid typhoid conjugate vaccine (Typbar TCV)","volume":"67","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0029","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/ciu078","article-title":"An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella typhi challenge delivered in sodium bicarbonate solution","volume":"58","author":"Waddington","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0030","first-page":"1","article-title":"Safety and immunogenicity of Salmonella typhi Vi conjugate vaccine (PedaTyphTM) in children up to five years","volume":"3","author":"Chinnasami","year":"2013","journal-title":"Int J Scientific Res Pub"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0031","first-page":"SC01","article-title":"A study on longevity of immune response after vaccination with Salmonella typhi Vi conjugate vaccine (Pedatyph\u2122) in children","volume":"9","author":"Chinnasami","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0032","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0033","doi-asserted-by":"crossref","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, immunogenicity and dose ranging of a new Vi-CRM\u2081\u2089\u2087 conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults","volume":"6","author":"van Damme","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019021500095836100_CIT0034","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/Supplement_1\/S22\/27783473\/ciy884.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T13:57:15Z","timestamp":1605189435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/Supplement_1\/S22\/5320174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":34,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2019,2,15]]},"published-print":{"date-parts":[[2019,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy884","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,15]]},"published":{"date-parts":[[2019,2,15]]}}}